| Mechanism of disease: Pulmonary hypertension. | |
| | |
MedLine Citation:
|
PMID: 20704929 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Extract: Pulmonary hypertension (PH) was previously termed primary (idiopathic or of unknown origin, i.e., spontaneous) or secondary (as a result of another disorder) pulmonary hypertension. It is now clear, however, that many of the entities labeled as secondary pulmonary hypertension resemble primary pulmonary hypertension in both their histopathological features and their response to treatment. For this reason, the World Health Organization (WHO) has recently classified PH into five groups on the basis of their proposed underlying mechanism. Group I in this classification, designated pulmonary arterial hypertension, is the focus of this overview. Pulmonary arterial hypertension (PAH) is defined as a sustained elevation of the pulmonary arterial pressure to greater than 25 mmHg at rest or greater than 30 mmHg following exercise, with a mean pulmonary-capillary wedge pressure (an indirect measure of left atrial pressure) of less than 15 mmHg. The entities within the category of PAH include idiopathic pulmonary arterial hypertension (IPAH; formerly, primary pulmonary hypertension), PAH associated with collagen vascular disease (e.g., in limited systemic sclerosis), portal hypertension (high pressure in the vessel that carries blood from the intestines to the liver), congenital left-to-right intra-cardiac shunts, infection with the human immunodeficiency virus (HIV), and persistent pulmonary hypertension of the newborn. The histological appearance of lung vessels in each of these conditions is similar: intimal fibrosis (formation of fibrous material in the inner lining of the blood vessel), increased medial thickness, pulmonary arteriolar occlusion (block of arterioles [the vessels that join the arteries and capillaries] in the lung), and plexiform (web-like) lesions predominate. |
| | |
Authors:
|
Harrison W Farber; Joseph Loscalzo |
Related Documents
:
|
23094209 - Study on branching pattern of aortic arch in indian. 15733509 - Descriptive patterns of severe chronic pulmonary hypertension by chest radiography. 12413209 - Prostacyclins in pulmonary hypertension treatment. 16121319 - Surgical and interventional therapies for pulmonary arterial hypertension. 17332729 - Bloodstream infections among patients treated with intravenous epoprostenol or intraven... 23022199 - A case of an extremely rare unilateral subscapular trunk and axillary artery variation ... 9131029 - Cerebral revascularization by omental free flap using contralateral superficial tempora... 3366969 - Hemifacial spasm caused by a tortuous vertebral artery: mr demonstration. 19337559 - Characterization of the vasodilatory action of testosterone in the human pulmonary circ... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Discovery medicine Volume: 5 ISSN: 1944-7930 ISO Abbreviation: Discov Med Publication Date: 2005 Feb |
Date Detail:
|
Created Date: 2010-08-13 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101250006 Medline TA: Discov Med Country: United States |
Other Details:
|
Languages: eng Pagination: 80-7 Citation Subset: - |
Affiliation:
|
Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pharmacokinetics of drugs administered in nanosuspension.
Next Document: Global gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive p...